US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Quasi-New Stocks

715.31

+3.320.47%

Number of Gainers:61

Number of Losers:118

Number of Flat:8

PE:- -

High:721.56

Open:711.90

Low:708.99

Close:711.98

Loading ...

BNY Mellon Increases Stake in Alterity Therapeutics

With a 54% Gain in 2025, This Artificial Intelligence (AI) Stock Is Crushing the S&P 500. Is It Too Late to Buy?

Rapport Therapeutics Reports Q1 2025 Financial Results

TRUMP Official: The transfer of 3.5 million TRUMP to a CEX was done to increase liquidity

Analysts are divided on Coinbase's acquisition of Deribit

DoubleVerify Reports Strong Q1 2025 Amid Caution

Press Release: LUCARA ANNOUNCES Q1 2025 RESULTS

Director Mirza Mansoor Raza Reports Disposal of Common Shares in Sera Prognostics Inc

Benjamin Jackson, General Counsel, Reports Disposal of Common Shares of Sera Prognostics Inc

Chief Information Officer Robert Gardner Reports Disposal of Sera Prognostics Inc. Common Shares

Chief Scientific Officer John J. Boniface Reports Disposal of Common Shares in Sera Prognostics Inc

ADVISORY-Alert on TaskUs withdrawn

Taskus Shareholders Unhappy With Merger Should Contact Shareholder Rights Firm Regarding Potential Legal Claims

THOMSON REUTERS

Rapid Dose Therapeutics Proposes Debt Settlement to Enhance Financial Position

HCW Biologics Inc. SVP Lee Flowers Reports Acquisition of Common Shares

TaskUs Enters Merger Agreement with Breeze Merger Corp

Why Krispy Kreme Stock Dove 16% on Friday

Altamira Therapeutics Announces June 2025 Annual General Meeting

Why Recursion Pharmaceuticals Stock Plummeted 24% This Week

Strong Buy Recommendation for Tenaya Therapeutics Amid Promising Trial Results and Financial Stability

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4539/news?page=22"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":715.30634,"timestamp":1747252799999,"preClose":711.9814,"halted":0,"volume":500403785,"delay":0,"changeRate":0.00467,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":3.324951,"latestTime":"05-14 16:00:00 EDT","open":711.8973,"high":721.5609,"low":708.9897,"amount":14418257629.051373,"amplitude":0.017657,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1747315800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":6.41141,"peRate":-1679.623043,"turnoverRate":0.036861,"increases":61,"decrements":119,"flats":5,"marketCap":515966872688.25,"floatMarketCap":365909459709.625},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":721.5609,"amplitude":0.017657,"preClose":711.9814,"low":708.9897,"pbRate":"6.41141","latestPrice":715.30634,"volume":500403785,"delay":0,"open":711.8973,"prevYearClose":648.26935,"prevWeekClose":641.2098,"prevMonthClose":599.1775,"prevQuarterClose":570.2879,"fiveDayClose":618.7284,"twentyDayClose":550.9332,"sixtyDayClose":812.4805,"secType":"PLATE","market":"US","turnoverRate":0.036861,"peRate":-1679.623043,"marketCap":515966872688.25,"floatMarketCap":365909459709.625,"timestamp":1747252799999,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":61,"down":118,"flat":8},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:22,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2534525840","title":"BNY Mellon Increases Stake in Alterity Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2534525840","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534525840?lang=en_us&edition=fundamental","pubTime":"2025-05-12 06:47","pubTimestamp":1747003629,"startTime":"0","endTime":"0","summary":"Alterity Therapeutics ( ($AU:ATH) ) has issued an update. The Bank of New York Mellon Corporation (BNYMC) has increased its voting power in Alterit...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bny-mellon-increases-stake-in-alterity-therapeutics?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bny-mellon-increases-stake-in-alterity-therapeutics?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BNY","LENZ","BK4139","BK4539","BK4007"],"gpt_icon":0},{"id":"2534828718","title":"With a 54% Gain in 2025, This Artificial Intelligence (AI) Stock Is Crushing the S&P 500. Is It Too Late to Buy?","url":"https://stock-news.laohu8.com/highlight/detail?id=2534828718","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534828718?lang=en_us&edition=fundamental","pubTime":"2025-05-11 22:23","pubTimestamp":1746973380,"startTime":"0","endTime":"0","summary":"The S&P 500 is in the red for the year amid as Trump's trade war heats up.Duolingo stock is up 54% year to date, as the company's digital subscriptions aren't subject to tariffs.The stock trades at a premium valuation right now.The S&P 500  is off to a bumpy start to 2025. It slumped to a low of 19% below its peak after President Donald Trump announced his \"Liberation Day\" tariffs on goods from nearly every country in the world in early April, but it has since rebounded somewhat. It's now down by just 8% or so from its high, and off by around 4% year to date.But some companies' stocks barely skipped a beat -- primarily those that aren't directly affected by Trump's global trade war, which mainly targets imported physical goods. Duolingo  operates the world's most popular digital language education platform, and tariffs don't apply to its subscriptions. The company continues to grow rapidly, which has propelled its stock to an eye-popping 54% gain in 2025 so far.Duolingo just raised its","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/05/11/with-a-54-gain-in-2025-this-artificial-intelligenc/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["BK4551","BK4023","VOO","BK4587","BK4539","SPY","BK4543","BK4528","BK4585","BK4588",".SPX","BK4613","DUOL","BK4204","AI"],"gpt_icon":1},{"id":"2534413079","title":"Rapport Therapeutics Reports Q1 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2534413079","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534413079?lang=en_us&edition=fundamental","pubTime":"2025-05-10 12:20","pubTimestamp":1746850828,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics, Inc. ( ($RAPP) ) has released its Q1 earnings. Here is a breakdown of the information Rapport Therapeutics, Inc. presented to...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/rapport-therapeutics-reports-q1-2025-financial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/rapport-therapeutics-reports-q1-2025-financial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LENZ","BK4539","RAPP","BK4139"],"gpt_icon":0},{"id":"2534490963","title":"TRUMP Official: The transfer of 3.5 million TRUMP to a CEX was done to increase liquidity","url":"https://stock-news.laohu8.com/highlight/detail?id=2534490963","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534490963?lang=en_us&edition=fundamental","pubTime":"2025-05-10 11:20","pubTimestamp":1746847200,"startTime":"0","endTime":"0","summary":"BlockBeats News, May 10th, the TRUMP official announced on social media today that it has transferred 3.5 million TRUMP to the trading platform to further support liquidity operations, helping ensure that both buyers and sellers can continue to access TRUMP.BlockBeats previously reported that the 3.5 million TRUMP transferred to CEX today includes:1.5 million coins  transferred to Binance;1 million coins  transferred to OKX;500,000 coins  transferred to Bybit;500,000 coins  transferred to Coinbase.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//en/flash/293246","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_live","symbols":["LU1861558580.USD","BK4585","BK4595","BK4535","LU1861559042.SGD","BK4554","BK4588","BK4516","BK4112","BK4600","BK4551","BK4596","BK4539"],"gpt_icon":1},{"id":"2534749994","title":"Analysts are divided on Coinbase's acquisition of Deribit","url":"https://stock-news.laohu8.com/highlight/detail?id=2534749994","media":"Blockbeats","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534749994?lang=en_us&edition=fundamental","pubTime":"2025-05-10 09:26","pubTimestamp":1746840360,"startTime":"0","endTime":"0","summary":"BlockBeats News, May 10: Coinbase chose to disclose its acquisition of Deribit to the market before the Thursday stock market close ahead of its earnings report. Benchmark analyst Mark Palmer pointed out that with more institutions adopting cryptocurrency, acquiring Deribit would allow Coinbase to \"immediately dominate in the rapidly growing derivatives space.\"Oppenheimer analyst Owen Lau further believes that this move will make Coinbase a \"strong challenger\" to Binance, Bybit, and OKX in the derivatives field, emphasizing that \"cryptocurrency options have weaker cyclicalities and stable demand regardless of market movements.\"However, Compass Point analysts Ed Engel and Joe Flynn pointed out that Deribit primarily serves institutional clients, which does not help increase Coinbase's retail-focused perpetual contract trading volume. The two analysts downgraded Coinbase to sell last week, reiterating that the U.S. retail trading market for Coinbase has become saturated. Michael Klena of","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//en/flash/293237","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_live","symbols":["BK4600","OPY","BK4588","COIN","BK4539","BK4112","BK4516","LU1861558580.USD","LU1861559042.SGD","BK4127","BK4535","BK4596","BK4551","BK4585","BK4595","BK4554"],"gpt_icon":1},{"id":"2534349600","title":"DoubleVerify Reports Strong Q1 2025 Amid Caution","url":"https://stock-news.laohu8.com/highlight/detail?id=2534349600","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534349600?lang=en_us&edition=fundamental","pubTime":"2025-05-10 09:24","pubTimestamp":1746840270,"startTime":"0","endTime":"0","summary":"Doubleverify Holdings, Inc. (($DV)) has held its Q1 earnings call. Read on for the main highlights of the call. DoubleVerify Holdings, Inc. recentl...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/doubleverify-reports-strong-q1-2025-amid-caution?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/doubleverify-reports-strong-q1-2025-amid-caution?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4023","BK4539","DV"],"gpt_icon":0},{"id":"2534930274","title":"Press Release: LUCARA ANNOUNCES Q1 2025 RESULTS","url":"https://stock-news.laohu8.com/highlight/detail?id=2534930274","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534930274?lang=en_us&edition=fundamental","pubTime":"2025-05-10 09:00","pubTimestamp":1746838800,"startTime":"0","endTime":"0","summary":"Lucara Diamond Corp.  today reports its results for the quarter ended March 31, 2025. All amounts are in U.S. dollars unless otherwise noted. PDF Version.-- In Q1 2025, the Company's revenue decreased to $30.3 million compared to. $39.5 million in Q1 2024, primarily due to fewer carats sold (Q1 2025:. 72,871 carats, Q1 2024: 93,560 carats), which resulted from having to. process lower-grade stockpile material because of unusually high January. proportion of lower-grade M/PK1 ore than planned higher-grade. EM/PK2 ore. Lower grade M/PK was mined due to a shift in the. This lower revenue outlook has led management to assess the Company's. -- Subsequent to Q1 2025, the lenders approved a draw of up to $28.0 million. from the Cost Overrun Reserve Account  in exchange for the. -- During Q1 2025, the Company recovered six stones over 100 carats. of the total carats recovered from direct ore feed in Q1 2025.ventilation shaft. At the end of Q1 2025, the production shaft had. -- A total of 93,71","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["S","BK4188","BK4561","LU2286300806.USD","LUCRF","BK4539","BK4560","BK4585","BK4588","BK4097"],"gpt_icon":0},{"id":"2534462598","title":"Director Mirza Mansoor Raza Reports Disposal of Common Shares in Sera Prognostics Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2534462598","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534462598?lang=en_us&edition=fundamental","pubTime":"2025-05-10 07:19","pubTimestamp":1746832754,"startTime":"0","endTime":"0","summary":"Mirza Mansoor Raza, a Director at Sera Prognostics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sera Prognostics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 09, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nNDL4Pz4ph:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","SERA"],"gpt_icon":0},{"id":"2534625934","title":"Benjamin Jackson, General Counsel, Reports Disposal of Common Shares of Sera Prognostics Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2534625934","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534625934?lang=en_us&edition=fundamental","pubTime":"2025-05-10 07:18","pubTimestamp":1746832695,"startTime":"0","endTime":"0","summary":"Benjamin Jackson, General Counsel of Sera Prognostics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sera Prognostics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 09, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nNDL6NmCcW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","SERA","BK4139"],"gpt_icon":0},{"id":"2534462560","title":"Chief Information Officer Robert Gardner Reports Disposal of Sera Prognostics Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2534462560","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534462560?lang=en_us&edition=fundamental","pubTime":"2025-05-10 07:18","pubTimestamp":1746832682,"startTime":"0","endTime":"0","summary":"Robert Gardner Harrison, Chief Information Officer of Sera Prognostics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sera Prognostics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 09, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nNDLTV9NX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","SERA","BK4139"],"gpt_icon":0},{"id":"2534462513","title":"Chief Scientific Officer John J. Boniface Reports Disposal of Common Shares in Sera Prognostics Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2534462513","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534462513?lang=en_us&edition=fundamental","pubTime":"2025-05-10 07:17","pubTimestamp":1746832664,"startTime":"0","endTime":"0","summary":"John J. Boniface, the Chief Scientific Officer of Sera Prognostics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sera Prognostics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 09, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nNDL9Bxm0W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","SERA"],"gpt_icon":0},{"id":"2534618194","title":"ADVISORY-Alert on TaskUs withdrawn","url":"https://stock-news.laohu8.com/highlight/detail?id=2534618194","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534618194?lang=en_us&edition=fundamental","pubTime":"2025-05-10 06:21","pubTimestamp":1746829310,"startTime":"0","endTime":"0","summary":"ADVISORY-Alert on TaskUs withdrawnAn alert on TaskUs TASK.O was inadvertently published off a press release from a law firm and has been withdrawn.There will be no substitute.STORY_NUMBER:nTUA4P42BYSTORY_DATE:09/05/2025STORY_TIME:10:02 PM GMT ((Bangalore.newsroom@thomsonreuters.com))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nTUA4P42BY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4539","TASK","BK4106","BK4226"],"gpt_icon":0},{"id":"2534469614","title":"Taskus Shareholders Unhappy With Merger Should Contact Shareholder Rights Firm Regarding Potential Legal Claims","url":"https://stock-news.laohu8.com/highlight/detail?id=2534469614","media":"THOMSON REUTERS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534469614?lang=en_us&edition=fundamental","pubTime":"2025-05-10 06:02","pubTimestamp":1746828125,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nTUA4P42BY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TASK","BK4226","BK4535","BK4539","BK4106"],"gpt_icon":0},{"id":"2534466227","title":"Rapid Dose Therapeutics Proposes Debt Settlement to Enhance Financial Position","url":"https://stock-news.laohu8.com/highlight/detail?id=2534466227","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534466227?lang=en_us&edition=fundamental","pubTime":"2025-05-10 05:39","pubTimestamp":1746826786,"startTime":"0","endTime":"0","summary":"Rapid Dose Therapeutics Corp ( ($TSE:DOSE) ) has shared an announcement. Rapid Dose Therapeutics Corp. has announced a proposed debt settlement wit...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/rapid-dose-therapeutics-proposes-debt-settlement-to-enhance-financial-position?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/rapid-dose-therapeutics-proposes-debt-settlement-to-enhance-financial-position?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4139","LENZ","BK4539"],"gpt_icon":0},{"id":"2534466686","title":"HCW Biologics Inc. SVP Lee Flowers Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2534466686","media":"Reuters","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534466686?lang=en_us&edition=fundamental","pubTime":"2025-05-10 05:30","pubTimestamp":1746826204,"startTime":"0","endTime":"0","summary":"Lee Flowers, the Senior Vice President of Business Development, reported an acquisition of common shares of HCW Biologics Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HCW Biologics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 09, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nNDL3YVJy5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","HCWB"],"gpt_icon":0},{"id":"2534466402","title":"TaskUs Enters Merger Agreement with Breeze Merger Corp","url":"https://stock-news.laohu8.com/highlight/detail?id=2534466402","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534466402?lang=en_us&edition=fundamental","pubTime":"2025-05-10 05:24","pubTimestamp":1746825846,"startTime":"0","endTime":"0","summary":"TaskUs ( ($TASK) ) has shared an announcement. On May 8, 2025, TaskUs, Inc. entered into a Merger Agreement with Breeze Merger Corporation, which w...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/taskus-enters-merger-agreement-with-breeze-merger-corp?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/taskus-enters-merger-agreement-with-breeze-merger-corp?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4106","BK4539","TASK","BK4535","BK4226"],"gpt_icon":0},{"id":"2534466840","title":"Why Krispy Kreme Stock Dove 16% on Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=2534466840","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534466840?lang=en_us&edition=fundamental","pubTime":"2025-05-10 05:20","pubTimestamp":1746825600,"startTime":"0","endTime":"0","summary":"More than one analyst cut their price target on the struggling donut maker.This closely followed the release of a disappointing quarterly earnings report.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/05/09/why-krispy-kreme-stock-dove-16-on-friday/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["BK4588","DNUT","BK4539","BK4209","BK4585"],"gpt_icon":0},{"id":"2534466276","title":"Altamira Therapeutics Announces June 2025 Annual General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2534466276","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534466276?lang=en_us&edition=fundamental","pubTime":"2025-05-10 05:19","pubTimestamp":1746825551,"startTime":"0","endTime":"0","summary":"Altamira Therapeutics ( ($CYTOF) ) has issued an announcement. Altamira Therapeutics Ltd. announced its upcoming Annual General Meeting of Sharehol...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/altamira-therapeutics-announces-june-2025-annual-general-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/altamira-therapeutics-announces-june-2025-annual-general-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CYTO","BK4539","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2534760465","title":"Why Recursion Pharmaceuticals Stock Plummeted 24% This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2534760465","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534760465?lang=en_us&edition=fundamental","pubTime":"2025-05-10 05:17","pubTimestamp":1746825420,"startTime":"0","endTime":"0","summary":"The results of a recent survey released Tuesday showed President Trump's actions are likely to make it harder for biotech companies like Recursion to raise capital.The company reported less-than-stellar earnings yesterday and announced it was ending the development of a significant portion of its pipeline.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/05/09/why-recursion-pharmaceuticals-stock-plummeted-24-t/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["BK4609","RXRX","BK4548","BK4611","BK4139","BK4539"],"gpt_icon":1},{"id":"2534468919","title":"Strong Buy Recommendation for Tenaya Therapeutics Amid Promising Trial Results and Financial Stability","url":"https://stock-news.laohu8.com/highlight/detail?id=2534468919","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534468919?lang=en_us&edition=fundamental","pubTime":"2025-05-10 04:15","pubTimestamp":1746821751,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Cory Jubinville, PhD maintained a Buy rating on Tenaya Therapeutics (TNYA – Research Report) today and set a price target o...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/strong-buy-recommendation-for-tenaya-therapeutics-amid-promising-trial-results-and-financial-stability?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/strong-buy-recommendation-for-tenaya-therapeutics-amid-promising-trial-results-and-financial-stability?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","TNYA","BK4007","LENZ","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":56,"pageCount":22,"totalSize":1111,"code":"91000000","status":"200"}]}}